Received Sep 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received first Shingrix shot in January; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix in Jan 2025). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: received first Shingrix shot in January). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 31-AUG-2025 The patient received first Shingrix shot in Jan 2025. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.